파상풍 톡소이드 백신 시장은 2024-2029년 13억 3,730만 달러 증가하고, 예측 기간 동안 CAGR 4.6%로 성장할 것으로 예측됩니다.
파상풍 톡소이드 백신 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 포함한 벤더 분석 등의 정보를 전해드립니다.
현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 시장은 라이선스 계약, 파상풍, 디프테리아, 백일해, 백일해 사례 증가, 백신 접종 및 예방 접종에 대한 정부 이니셔티브의 증가에 의해 주도되고 있습니다.
| 시장 범위 |
| 기준 연도 |
2025년 |
| 종료 연도 |
2029 |
| 예측 기간 |
2025-2029년 |
| 성장 모멘텀 |
가속 |
| 전년비 |
4.4% |
| CAGR |
4.6% |
| 증가액 |
13억 3,730만 달러 |
이 조사는 업계 주요 참가자의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서에는 주요 기업 분석, 종합적인 시장 규모 데이터, 지역별 분석에 따른 부문, 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 있습니다.
이 보고서는 향후 몇 년 동안 파상풍 톡소이드 백신 시장의 성장을 촉진하는 주요 요인 중 하나로 신제품 출시를 꼽고 있습니다. 또한, 예방접종 캠페인의 증가와 임상시험의 증가는 시장의 큰 수요로 이어질 것입니다.
목차
제1장 주요 요약
제2장 Technavio 분석
- 가격·수명주기·고객 구입 바스켓·채용률·구입 기준 분석
- 인풋의 중요성과 차별화 요인
- 혼란 요인
- 성장 촉진요인과 과제의 영향
제3장 시장 상황
제4장 시장 규모
- 시장 정의
- 시장 부문 분석
- 시장 규모 2024년
- 시장 전망 2024-2029년
제5장 시장 규모 실적
- 파상풍 톡소이드 백신 세계 시장 2019-2023년
- 연령층별 부문 분석 2019-2023년
- 약물 클래스별 부문 분석 2019-2023년
- 최종사용자별 부문 분석 2019-2023년
- 지역별 부문 분석 2019-2023년
- 국가별 부문 분석 2019-2023년
제6장 정성 분석
- AI의 영향 : 파상풍 톡소이드 백신 세계 시장
제7장 Five Forces 분석
- Five Forces 요약
- 구매자의 교섭력
- 공급 기업의 교섭력
- 신규 참여업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 상황
제8장 시장 세분화 : 연령층별
- 시장 부문
- 비교 : 연령층별
- 신생아 : 시장 규모와 예측 2024-2029년
- 성인 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 연령층별
제9장 시장 세분화 : 약물 종류별
- 시장 부문
- 비교 : 약물 종류별
- 조합 : 시장 규모와 예측 2024-2029년
- 1가 파상풍 톡소이드 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 약물 종류별
제10장 시장 세분화 : 최종사용자별
- 시장 부문
- 비교 : 최종사용자별
- 병원 : 시장 규모와 예측 2024-2029년
- 전문 클리닉 : 시장 규모와 예측 2024-2029년
- 공중위생 기관 : 시장 규모와 예측 2024-2029년
- 외래 진료 센터 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 최종사용자별
제11장 고객 상황
제12장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측 2024-2029년
- 유럽 : 시장 규모와 예측 2024-2029년
- 아시아 : 시장 규모와 예측 2024-2029년
- 세계 기타 지역 : 시장 규모와 예측 2024-2029년
- 미국 : 시장 규모와 예측 2024-2029년
- 독일 : 시장 규모와 예측 2024-2029년
- 영국 : 시장 규모와 예측 2024-2029년
- 중국 : 시장 규모와 예측 2024-2029년
- 프랑스 : 시장 규모와 예측 2024-2029년
- 이탈리아 : 시장 규모와 예측 2024-2029년
- 캐나다 : 시장 규모와 예측 2024-2029년
- 멕시코 : 시장 규모와 예측 2024-2029년
- 스페인 : 시장 규모와 예측 2024-2029년
- 일본 : 시장 규모와 예측 2024-2029년
- 시장 기회 : 지역 상황별
제13장 촉진요인, 과제, 기회, 억제요인
- 시장 성장 촉진요인
- 시장 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회·억제요인
제14장 경쟁 구도
제15장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- Actiza Pharmaceutical Pvt. Ltd.
- AJ Vaccines AS
- Avalon Pharma Pvt. Ltd.
- Bharat Biotech Ltd.
- CSL Ltd.
- Emergent BioSolutions Inc.
- GlaxoSmithKline Plc
- Incepta Vaccine Ltd.
- Meiji Holdings Co. Ltd.
- Merck and Co. Inc.
- Panacea Biotec Ltd.
- Pfizer Inc.
- Sanofi SA
- Serum Institute of India Pvt. Ltd.
- Shenzhen Kangtai Biological Products Co. Ltd.
제16장 부록
ksm
The tetanus toxoid vaccine market is forecasted to grow by USD 1,337.3 mn during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the tetanus toxoid vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by licensing agreements, rising cases of tetanus, diphtheria, and pertussis, and increasing government initiatives regarding vaccination and immunization.
| Market Scope |
|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 4.4% |
| CAGR | 4.6% |
| Incremental Value | $1,337.3 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's tetanus toxoid vaccine market is segmented as below:
By Age Group
By Drug Class
- Monovalent tetanus toxoid
- Combination
By End-user
- Hospitals
- Specialty clinics
- Public health agencies
- Ambulatory care centers
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the new product launches as one of the prime reasons driving the tetanus toxoid vaccine market growth during the next few years. Also, increasing number of immunization campaigns and increasing clinical trials will lead to sizable demand in the market.
The report on the tetanus toxoid vaccine market covers the following areas:
- Tetanus Toxoid Vaccine Market sizing
- Tetanus Toxoid Vaccine Market forecast
- Tetanus Toxoid Vaccine Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tetanus toxoid vaccine market vendors that include Actiza Pharmaceutical Pvt. Ltd., AJ Vaccines AS, Amson Vaccines and Pharma Pvt Ltd., Avalon Pharma Pvt. Ltd., Bharat Biotech Ltd., CSL Ltd., Dano Vaccines and Biologicals Pvt. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Incepta Vaccine Ltd., Meiji Holdings Co. Ltd., Merck and Co. Inc., Microgen, Panacea Biotec Ltd., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., and Shenzhen Kangtai Biological Products Co. Ltd.. Also, the tetanus toxoid vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Age Group
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Tetanus Toxoid Vaccine Market 2019 - 2023
- Historic Market Size - Data Table on Global Tetanus Toxoid Vaccine Market 2019 - 2023 ($ million)
- 5.2 Age Group segment analysis 2019 - 2023
- Historic Market Size - Age Group Segment 2019 - 2023 ($ million)
- 5.3 Drug Class segment analysis 2019 - 2023
- Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
- 5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 The AI impact on global tetanus toxoid vaccine market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Age Group
- 8.1 Market segments
- Chart on Age Group - Market share 2024-2029 (%)
- Data Table on Age Group - Market share 2024-2029 (%)
- 8.2 Comparison by Age Group
- Chart on Comparison by Age Group
- Data Table on Comparison by Age Group
- 8.3 Neonatals - Market size and forecast 2024-2029
- Chart on Neonatals - Market size and forecast 2024-2029 ($ million)
- Data Table on Neonatals - Market size and forecast 2024-2029 ($ million)
- Chart on Neonatals - Year-over-year growth 2024-2029 (%)
- Data Table on Neonatals - Year-over-year growth 2024-2029 (%)
- 8.4 Adults - Market size and forecast 2024-2029
- Chart on Adults - Market size and forecast 2024-2029 ($ million)
- Data Table on Adults - Market size and forecast 2024-2029 ($ million)
- Chart on Adults - Year-over-year growth 2024-2029 (%)
- Data Table on Adults - Year-over-year growth 2024-2029 (%)
- 8.5 Market opportunity by Age Group
- Market opportunity by Age Group ($ million)
- Data Table on Market opportunity by Age Group ($ million)
9 Market Segmentation by Drug Class
- 9.1 Market segments
- Chart on Drug Class - Market share 2024-2029 (%)
- Data Table on Drug Class - Market share 2024-2029 (%)
- 9.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- 9.3 Combination - Market size and forecast 2024-2029
- Chart on Combination - Market size and forecast 2024-2029 ($ million)
- Data Table on Combination - Market size and forecast 2024-2029 ($ million)
- Chart on Combination - Year-over-year growth 2024-2029 (%)
- Data Table on Combination - Year-over-year growth 2024-2029 (%)
- 9.4 Monovalent tetanus toxoid - Market size and forecast 2024-2029
- Chart on Monovalent tetanus toxoid - Market size and forecast 2024-2029 ($ million)
- Data Table on Monovalent tetanus toxoid - Market size and forecast 2024-2029 ($ million)
- Chart on Monovalent tetanus toxoid - Year-over-year growth 2024-2029 (%)
- Data Table on Monovalent tetanus toxoid - Year-over-year growth 2024-2029 (%)
- 9.5 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
10 Market Segmentation by End-user
- 10.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 10.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 10.3 Hospitals - Market size and forecast 2024-2029
- Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
- 10.4 Specialty clinics - Market size and forecast 2024-2029
- Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
- Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
- Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
- 10.5 Public health agencies - Market size and forecast 2024-2029
- Chart on Public health agencies - Market size and forecast 2024-2029 ($ million)
- Data Table on Public health agencies - Market size and forecast 2024-2029 ($ million)
- Chart on Public health agencies - Year-over-year growth 2024-2029 (%)
- Data Table on Public health agencies - Year-over-year growth 2024-2029 (%)
- 10.6 Ambulatory care centers - Market size and forecast 2024-2029
- Chart on Ambulatory care centers - Market size and forecast 2024-2029 ($ million)
- Data Table on Ambulatory care centers - Market size and forecast 2024-2029 ($ million)
- Chart on Ambulatory care centers - Year-over-year growth 2024-2029 (%)
- Data Table on Ambulatory care centers - Year-over-year growth 2024-2029 (%)
- 10.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
- 12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 12.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 12.9 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 12.10 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 12.11 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 12.12 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 12.13 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 12.14 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- 12.15 Spain - Market size and forecast 2024-2029
- Chart on Spain - Market size and forecast 2024-2029 ($ million)
- Data Table on Spain - Market size and forecast 2024-2029 ($ million)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
- 12.16 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
- 13.1 Market drivers
- 13.2 Market challenges
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities/restraints
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- 15.2 Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Actiza Pharmaceutical Pvt. Ltd.
- Actiza Pharmaceutical Pvt. Ltd. - Overview
- Actiza Pharmaceutical Pvt. Ltd. - Product / Service
- Actiza Pharmaceutical Pvt. Ltd. - Key offerings
- SWOT
- 15.5 AJ Vaccines AS
- AJ Vaccines AS - Overview
- AJ Vaccines AS - Product / Service
- AJ Vaccines AS - Key offerings
- SWOT
- 15.6 Avalon Pharma Pvt. Ltd.
- Avalon Pharma Pvt. Ltd. - Overview
- Avalon Pharma Pvt. Ltd. - Product / Service
- Avalon Pharma Pvt. Ltd. - Key offerings
- SWOT
- 15.7 Bharat Biotech Ltd.
- Bharat Biotech Ltd. - Overview
- Bharat Biotech Ltd. - Product / Service
- Bharat Biotech Ltd. - Key offerings
- SWOT
- 15.8 CSL Ltd.
- CSL Ltd. - Overview
- CSL Ltd. - Business segments
- CSL Ltd. - Key news
- CSL Ltd. - Key offerings
- CSL Ltd. - Segment focus
- SWOT
- 15.9 Emergent BioSolutions Inc.
- Emergent BioSolutions Inc. - Overview
- Emergent BioSolutions Inc. - Product / Service
- Emergent BioSolutions Inc. - Key offerings
- SWOT
- 15.10 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- 15.11 Incepta Vaccine Ltd.
- Incepta Vaccine Ltd. - Overview
- Incepta Vaccine Ltd. - Product / Service
- Incepta Vaccine Ltd. - Key offerings
- SWOT
- 15.12 Meiji Holdings Co. Ltd.
- Meiji Holdings Co. Ltd. - Overview
- Meiji Holdings Co. Ltd. - Business segments
- Meiji Holdings Co. Ltd. - Key offerings
- Meiji Holdings Co. Ltd. - Segment focus
- SWOT
- 15.13 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- 15.14 Panacea Biotec Ltd.
- Panacea Biotec Ltd. - Overview
- Panacea Biotec Ltd. - Product / Service
- Panacea Biotec Ltd. - Key news
- Panacea Biotec Ltd. - Key offerings
- SWOT
- 15.15 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- 15.16 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- 15.17 Serum Institute of India Pvt. Ltd.
- Serum Institute of India Pvt. Ltd. - Overview
- Serum Institute of India Pvt. Ltd. - Product / Service
- Serum Institute of India Pvt. Ltd. - Key offerings
- SWOT
- 15.18 Shenzhen Kangtai Biological Products Co. Ltd.
- Shenzhen Kangtai Biological Products Co. Ltd. - Overview
- Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
- Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- 16.5 Data procurement
- 16.6 Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
